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JANUARY – MARCH, 2020 
Marcella H. Sorg, PhD 
Margaret Chase Smith Policy Center 
University of Maine 
 
This report, funded by the Maine Office of Attorney General, provides a summary of statistics regarding 
drug fatalities in Maine during January-March, 2020, as well as preliminary estimates for April-June.  
Data for the report were collected at the Office of Chief Medical Examiner. A “drug death” is identified 
when one or more drugs are mentioned on the death certificate as a cause or significant contributing 




During the first quarter of 2020, total fatalities due to drugs are 23% higher than the fourth quarter of 
2019: 127 compared to 103. The estimated total for the second quarter is 132, with a total of 259 
estimated for the first half of 2020.  The overall increase, comparing 2019 and the estimate for the first 
half of 2020, is statistically significant (p=.0039).  It is comparable to increases being seen nationally, 
which are attributed to the effects of the pandemic, including social isolation, economic difficulty, and 
reluctance to seek medical attention. Interruptions in drug supplies internationally have resulted in 
substitutions and combinations that may be contributing to additional vulnerabilities to overdose. 
 
Opioids (both pharmaceutical and nonpharmaceutical) were implicated in 82% of first quarter deaths. 
Nonpharmaceutical fentanyl drugs in particular were implicated in 61% of deaths, and 68% of opioid 
deaths, which is a reduction since 2019 when fentanyl caused 68% of all drug deaths, and 81% of opioid 
deaths.  Most first quarter deaths, 80%, involved two or more drugs listed as a cause of death. 
Nonpharmaceutical opioid deaths were very likely to have co-intoxicant stimulants, cocaine or 
methamphetamine, increasing since 2019. Pharmaceutical opioids caused 27% of deaths, many in 
combination with nonpharmaceutical opioids. About a third of opioid deaths (35, 34%) had received 
naloxone, a higher number but the same proportion as in the fourth quarter 2019 (29, 34%). 
 
Using data from April and May as an estimate for the second quarter, the same general patterns 
continue from the first quarter, but with a higher proportion of deaths involving two or more drugs 
(87%), a higher proportion of deaths due to opioids (86%), and a higher proportion of deaths due to 
nonpharmaceutical fentanyl and its analogs (71%).   There is a rise in the proportion of deaths including 
cocaine as a cause of death (36% compared to 30% in the first quarter), but a lower proportion caused 
by methamphetamine (12% compared to 16%). Pharmaceutical opioids were implicated in 24% of 
deaths, slightly lower than 27% in the first quarter;  they were frequently in combination with 
nonpharmaceutical opioids.  Naloxone was present in 35% of the opioid deaths, approximately the same 





First Quarter Statistics 
 
Manners of death: Of these 127 deaths, 114 (90%) were accidental overdoses and 10 (8%) were 
suicides.  
 
Overall patterns of note:  
• Most (101, 80%) drug deaths were caused by two or more drugs, which is greater in number and 
less in proportion than the fourth quarter 2019 (94, 91%). The average cause of death involved 3 
drugs. 
• The vast majority of overdoses (104, 82%) were caused by at least one opioid, including both 
pharmaceutical and illicit (nonpharmaceutical) opioid drugs. This is greater in number and nearly the 
same proportion as in the fourth quarter 2019 (85, 83%). 
• Nonpharmaceutical fentanyl (and/or its analogs) caused 77 (61%) deaths, alone or in combination 
with other drugs, which is higher in number but much lower in proportion than the fourth quarter of 
2019 (72, 70%). 
• Heroin/morphine caused 18 (14%) deaths, in combination with other drugs, which is about the same 
in number but lower in proportion than fourth quarter 2019 (17, 17%).  
• Cocaine or crack caused 38 (30%) deaths, in combination with other drugs, which is higher in 
number but about the same proportion compared to fourth quarter 2019 (30, 29%).  
• Methamphetamine caused 20 (16%) deaths, in combination with other drugs, which is slightly 
higher in number and slightly lower in proportion compared to fourth quarter 2019 (18, 17%). 
• Pharmaceutical opioid deaths caused 34 (27%) deaths, alone or in combination with other drugs, 
which is higher in number and about the same proportion as in fourth quarter 2019 (27, 26%). 
• Naloxone was given in 35 (28%) opioid deaths, which is higher in number and the same proportion 
as in fourth quarter 2019 (29, 28%).1 
• There has been an increase in the involvement of mitragynine2 (“Kratom”) in Maine deaths, 5 in this 
quarter, compared with 1 in the fourth quarter 2019, and 10 in 2019 as a whole. 
 
 
Table 1. Demographic patterns 
 Total Average Age Age Range Percent Male 
All drug deaths 127 43 16-96 90 (71%) 
Accidents 114 42 16-96 81 (71%) 





                                                        
1 Naloxone may be given by family or friends at the scene, by police or emergency medical services who respond, 
or by the emergency department for those brought to the hospital.  Unfortunately, most decedents are alone in 
their residence when they ingest opioids and are not discovered in time for naloxone administration.   
2 Mitragynine is not an opioid, but is an alkaloid derived from a Southeast Asian plant, Kratom. It is attracted to the 
opioid receptors in the brain, and is opioid-like in its effects. 
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Table 2. Involvement of specific drug categories 
Specific drug or drug category causing the death (alone or in 
combination with other drugs and/or alcohol) 
 
Number 
Percent of 127 
drug deaths 
Number of deaths caused by more than one drug 92 72% 
Any pharmaceutical drug 84 66% 
Any pharmaceutical opioid drug 34 27% 
Any opioid (pharmaceutical or nonpharmaceutical) 




Any illicitly manufactured drug (includes heroin/morphine, 
nonpharmaceutical fentanyl, fentanyl analogs, other illicitly-







Any nonpharmaceutical opioid drugs (heroin/morphine, fentanyl, 





Heroin/morphine and/or fentanyl or fentanyl analogs 79 62% 
Fentanyl and/or fentanyl analogs (known pharmaceutical fentanyl 
removed) 
77 61% 
Heroin/morphine (known pharmaceutical morphine removed) 18 14% 
Any benzodiazepine 28 22% 
Cocaine 38 30% 
Methamphetamine 20 16% 
Mitragynine (“Kratom”) 5 4% 
*Excludes cases with buprenorphine in toxicology. 
 
 
Nonpharmaceutical Fentanyl and/or Fentanyl Analog Deaths 
 
This category includes deaths caused by nonpharmaceutical (illicitly manufactured) fentanyl or fentanyl 
analogs. We removed all cases that involved known pharmaceutical fentanyl from these totals. There 
were 77 overdoses due to nonpharmaceutical fentanyl and/or fentanyl analogs in the first quarter of 
2020.  The total has risen sharply beginning in the fourth quarter of 2013 (Figure 2). The gender 




Table 3. Involvement of co-intoxicant drugs in nonpharmaceutical fentanyl deaths 
 
 
Specific co-intoxicants in addition to fentanyl and/or 










FENTANYL and FENTANYL ANALOG COMBINATIONS   















CO-INTOXICANTS IDENTIFIED IN FENTANYL and/or 
FENTANYL ANALOG DEATHS   
• One or more drugs (or alcohol) in addition to 





• One or more pharmaceutical opioids in addition to 

















• One or more benzodiazepines in addition to fentanyl 





















Figure 1. Quarterly frequency of deaths due to nonpharmaceutical fentanyl, alone or in combination 







































































































Frequency of Deaths due to Nonpharmaceutical Fentanyl
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4-ANPP Fentanyl 2 18% 
Acetyl Fentanyl 7 64% 
Parafluoroisobutyryl Fentanyl 1 1% 





Heroin/morphine deaths include any death in which the cause of death identifies “heroin” or 
“morphine.”  We have removed all cases involving known pharmaceutical morphine, so the 
heroin/morphine deaths are all suspected heroin overdoses. In the first quarter of 2020 there were 18 
deaths due to (nonpharmaceutical) heroin/morphine alone or in combination with other drugs, 14% of 
all drug deaths. In the fourth quarter of 2019 there were 17 heroin deaths, 16% of all drug deaths. 
 
 
Table 5. Involvement of co-intoxicant drugs in heroin/morphine deaths 
 
Specific co-intoxicants in addition to 
heroin/morphine identified on the death certificate 




















Nonpharmaceutical fentanyl and/or at least one 





Alcohol in addition to heroin/morphine 3 17% 













Stimulants Cocaine and Methamphetamine 
 
Deaths involving the illicit stimulants cocaine and methamphetamine have been increasing in the past 
few years (Figure 3). The vast majority of these deaths also include co-intoxicant nonpharmaceutical 
opioids fentanyl, fentanyl analogs, or heroin. In the first quarter of 2020 there were 38 cocaine deaths; 
of these, 29 (76%) were caused by cocaine in combination with nonpharmaceutical fentanyl. Likewise, 
during the first quarter of 2020, there were 34 methamphetamine deaths; of these, 16 (80%) were 




Figure 2. Quarterly frequency of deaths due to cocaine or methamphetamine, alone or in combination 






The frequency of deaths in which at least one pharmaceutical opioid is mentioned on the death 
certificate as a cause of death has declined slightly over the past decade, although there was a slight 
increase between fourth quarter 2019 and first quarter 2020, from 27 to 34 (see Figure 4). Of the 34 
pharmaceutical opioid death cases, 18 (53%) had a current prescription for one of the opioids listed as a 
cause of death. Key pharmaceutical opioids included buprenorphine (11, 32%), oxycodone (10, 29%), 







































































































Frequency of Deaths Due to Cocaine Compared to Methamphetmaine
Cocaine Methamphetamine
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All of the pharmaceutical opioid deaths included other drugs or alcohol listed as a co-intoxicant cause of 
death.  Most had three or more.  Half (17, 50%) had at least one illicit drug listed as a cause of death.  
About one third (11, 32%) included nonpharmaceutical fentanyl, and about a fifth (7, 21%) included 





Figure 3. Quarterly frequency of deaths due to pharmaceutical opioids, alone or in combination with 
















































































































This table provides totals for counties during the first three months of 2019.  The reader is cautioned 
that, because the numbers for individual counties are relatively small, fluctuations are likely to be due 




Table 6.  Total drug deaths by county for 2019 and first quarter 2020, compared to the county’s 
percent of Maine census population 
County 
2019 
N = 380 
1st Quarter 
2020  
N = 127 
Percent of Maine 
Estimated Census 
Population, 2019 
Androscoggin 33   (9%) 10   (8)% 8% 
Aroostook 14   (4%) 5   (4)% 5% 
Cumberland 100 (26%) 24 (19)% 22% 
Franklin 5   (1%) 5   (4)% 2% 
Hancock 9   (2%) 4   (3)% 4% 
Kennebec 42 (11%) 13 (10)% 9% 
Knox 7   (2%) 5   (4)% 3% 
Lincoln 11   (3%) 2   (2)% 3% 
Oxford 9   (2%) 2   (2)% 4% 
Penobscot 53 (14%) 20 (16)% 11% 
Piscataquis 3   (1%) 4   (3)% 1% 
Sagadahoc 8   (2%) 1   (1)% 3% 
Somerset 16   (4%) 4   (3)% 4% 
Waldo 3   (1%) 1   (1)% 3% 
Washington 10   (3%) 7   (6)% 2% 
York 57 (15%) 20 (16)% 15% 
 
 
 
